Who invested in Fusion Pharamaceuticals?
Fusion Pharamaceuticals's investors include OrbiMed, Varian, Perceptive Advisors, TPG and Adams Street Partners, and 7 more on record. OrbiMed led its latest round.
Canada · Series B startup
One round we have observed, with the 12 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$105Mraised across 1 round since 2019, from 1 source
Reported by FinSMEs
Fusion Pharamaceuticals's investors include OrbiMed, Varian, Perceptive Advisors, TPG and Adams Street Partners, and 7 more on record. OrbiMed led its latest round.
Fusion Pharamaceuticals has raised $105M across 1 round since 2019.
Fusion Pharamaceuticals's most recent round was a Series B of $105M in Apr 2019, led by OrbiMed.
Its most recent round, $105M in Apr 2019, is also its largest on record.
Fusion Pharamaceuticals's first round on record, in Apr 2019, was backed by OrbiMed, Varian and Perceptive Advisors and 9 others.
Fusion Pharamaceuticals's latest named round is a Series B, in Apr 2019.
Fusion Pharamaceuticals is based in Canada.
OrbiMed led the Series B in 2019.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.